ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion.

Autor: Gnosa SP; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Puig Blasco L; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Piotrowski KB; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Freiberg ML; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Savickas S; Department of Biotechnology and Biomedicine, Technical University of Denmark, Copenhagen, Denmark., Madsen DH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Auf dem Keller U; Department of Biotechnology and Biomedicine, Technical University of Denmark, Copenhagen, Denmark., Kronqvist P; Institute of Biomedicine and.; Department of Pathology, University of Turku, Turku, Finland., Kveiborg M; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.

Publikováno v: JCI insight [JCI Insight] 2022 Sep 22; Vol. 7 (18). Date of Electronic Publication: 2022 Sep 22.